• News & Media
  • Contact
  • Home
  • About Us
    • Our Commitment
    • The Story Behind Our Name
    • Leadership
    • Board of Directors
    • Grants & Funding
    • Investigator Sponsored Studies
    • Compliance Declaration
  • Our Approach
    • Precision Medicines
    • Overcoming Resistance
    • Novel Biomarkers
  • Pipeline
    • Menin Inhibition
    • Farnesyl Transferase Inhibitors
    • Posters and Presentations
    • Scientific Manuscripts
    • Access To Investigational Drugs Outside a Clinical Study
  • Patients & Caregivers
    • Acute Leukemias
    • Head & Neck Cancer
  • Our Medicine
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Analyst Coverage
    • FAQs
    • Contact
  • Careers
    • Values
    • Life At Kura
    • Benefits
    • Open Positions
  • News & Media
  • Contact
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

University General Hospital of Athens Attikon

September 22, 2022/in AIM, Global, Greece
Read more
/wp-content/uploads/Kura_Logo_2024_RGB.svg 0 0 eallison /wp-content/uploads/Kura_Logo_2024_RGB.svg eallison2022-09-22 14:39:392022-09-22 14:39:39University General Hospital of Athens Attikon

University General Hospital of Larissa

September 22, 2022/in AIM, Global, Greece
Read more
/wp-content/uploads/Kura_Logo_2024_RGB.svg 0 0 eallison /wp-content/uploads/Kura_Logo_2024_RGB.svg eallison2022-09-22 14:37:322022-09-22 14:37:32University General Hospital of Larissa

Bioclinic – Thessaloniki

September 22, 2022/in AIM, Global, Greece
Read more
/wp-content/uploads/Kura_Logo_2024_RGB.svg 0 0 eallison /wp-content/uploads/Kura_Logo_2024_RGB.svg eallison2022-09-22 14:36:492022-09-22 14:36:49Bioclinic – Thessaloniki
  • About Us
  • Our Commitment
  • The Story Behind Our Name
  • Leadership
  • Board of Directors
  • Grants & Funding
  • Investigator Sponsored Studies
  • Compliance Declaration
  • Our Approach
  • Precision Medicines
  • Overcoming Resistance
  • Novel Biomarkers
  • Pipeline
  • Menin Inhibition
  • Farnesyl Transferase Inhibitors
  • Posters and Presentations
  • Scientific Manuscripts
  • Access to Investigational Drugs Outside a Clinical Study
  • Patients & Caregivers
  • Acute Leukemias
  • Head & Neck Cancer
  • Our Medicine
  • Investors
  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financial Information
  • Analyst Coverage
  • FAQs
  • Contact
  • Careers
  • Values
  • Life at Kura
  • Benefits
  • Open Positions
  • News & Media
  • Press Releases
  • News & Perspectives
  • Expert Perspectives
  • Media Resources
  • Contact

Kura Oncology, Inc.
4930 Directors Place, Suite 500
San Diego, CA 92121
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

© 2025 Kura Oncology, Inc. All Rights Reserved | Terms of Use | Privacy Policy | Cookie Policy | Consumer Health Data

Scroll to top Scroll to top Scroll to top